|Bid||2.31 x 0|
|Ask||2.34 x 0|
|Day's range||2.32 - 2.38|
|52-week range||1.71 - 2.59|
|Beta (3Y monthly)||1.52|
|PE ratio (TTM)||45.49|
|Earnings date||21 Aug. 2017 - 25 Aug. 2017|
|Forward dividend & yield||0.07 (3.22%)|
|1y target est||2.29|
The Healthscope Ltd (ASX:HSO) share price has rocketed higher this morning following the receipt of another takeover approach...
The Healthscope Ltd (ASX:HSO) share price has been a big mover on Tuesday after receiving another takeover. Will it go through this time?
A bidding group led by buyout firm BGH Capital and pension fund AustralianSuper on Tuesday made a fresh A$4.1 billion ($2.9 billion) takeover approach for hospital operator Healthscope Ltd., five months after having a similar bid rejected as too low. Since then, Healthscope shares have plunged as much as 30 percent, closing Monday at an eight-month low of A$1.785. Healthscope in May also rejected a A$2.50 a share bid from Canada’s Brookfield Asset Management Inc.
I am writing today to help inform people who are new to the stock market and want to begin learning the link between Healthscope Limited (ASX:HSO)’s return fundamentals and stockRead More...
Healthscope Limited (ASX:HSO) is trading with a trailing P/E of 26.2x, which is higher than the industry average of 20.2x. Although some investors may jump to the conclusion that youRead More...
Australian hospital operator Healthscope Ltd. said two competing takeover bids both undervalue the company and it won’t open its books to either suitor. Instead, Healthscope said Tuesday it was exploring whether to sell and lease back any of its 29 freehold properties, which have a book value of about A$1.3 billion ($986 million). Canada’s Brookfield Asset Management Inc. last week offered A$4.35 billion, or A$2.50 a share, in cash for Healthscope, topping a bid from private equity firm BGH Capital.